About this trial
The purpose the research is to prospectively demonstrate agreement between EHR and ambulatory blood pressure monitor (ABPM) derived blood pressure variability (BPV), as well as the feasibility of reducing BPV using a data-driven pharmacotherapeutic approach. To this end, this is a feasibility study that will make use of the Cedars-Sinai Health System including the Medical Delivery Network and the clinics of all practitioners who use the same EHR.
Eligibility criteria
Qualifiers
Individuals 18 years old or older are included.
Patients followed continuously at Cedars-Sinai for at least 5 years, defined as at least 1 outpatient visit with a Cedars-Sinai physician at which a blood pressure was measured each of the last 2 calendar years
Patients with a PCP in the Cedars-Sinai Medical Group or faculty practice
Patients on antihypertensive therapy other than a DPH-CCB or thiazide-like diuretic
Disqualifiers
Any records flagged "break the glass" or "research opt out."
Pregnant or breastfeeding patients (due to guideline recommendations for specific medications for the treatment of hypertension during pregnancy and breastfeeding).
Trial design
Treatments tested in this trial
- Low BPV Regimen